Publication:
First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis

Placeholder

Organizational Units

Program

Authors

Authors

GÜMÜŞ, MAHMUT
Turk, H.
Bilir, C.
Sendur, M.
Karabulut, B.
Artac, M.
Cicin, I.
Geredeli, C.
Alacacioglu, A.
Kefeli, U.

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Description

Source:

Keywords:

Keywords

Citation

Isikdogan A., Turk H., Bilir C., Sendur M., Karabulut B., Artac M., Cicin I., Geredeli C., Alacacioglu A., Kefeli U., et al., -First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis-, ANNALS OF ONCOLOGY, cilt.33, 2022

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals

Thumbnail Image
Goal